Braley, Tiffany J.Whibley, DanielAlschuler, Kevin NEhde, DawnChervin, Ronald DClauw, Daniel J.Williams, DavidKratz, Anna L.2020-11-242020-11-242020Braley, T J, Whibley, D, Alschuler, K N, Ehde, D, Chervin, R D, Clauw, D J, Williams, D & Kratz, A L 2020, 'Cannabinoid use among Americans with MS : Current trends and gaps in knowledge', Multiple sclerosis journal, vol. 6, no. 3, pp. 1-12. https://doi.org/10.1177/20552173209598161352-4585PubMedCentral: PMC7518014SCOPUS: 85101595843https://hdl.handle.net/2164/15405Acknowledgements: The National Multiple Sclerosis Society (NMSS) provided participant recruitment support. The Michigan Institute for Clinical & Health Research (MICHR:NIH award number UL1TR002240) provided participant recruitment support through UMHealthResearch.org. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NMSS. The investigators thank Shubha Kulkarni for her assistance with data collection.12498812engMultiple sclerosiscannabinoidscannabispaininsomniasleep disturbanceR MedicineClinical NeurologyNeurologyRCannabinoid use among Americans with MS : Current trends and gaps in knowledgeJournal article10.1177/2055217320959816http://www.scopus.com/inward/record.url?scp=0034021266&partnerID=8YFLogxK63